AAAAAA
Results: 1-25/53
Authors:
Kasher, R
Balass, M
Scherf, T
Fridkin, M
Fuchs, S
Katchalski-Katzir, E
Citation: R. Kasher et al., Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity, CHEM BIOL, 8(2), 2001, pp. 147-155
Authors:
Harel, M
Kasher, R
Nicolas, A
Guss, JM
Balass, M
Fridkin, M
Smit, AB
Brejc, K
Sixma, TK
Katchalski-Katzir, E
Sussman, JL
Fuchs, S
Citation: M. Harel et al., The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex between alpha-bungarotoxin and a mimotope peptide, NEURON, 32(2), 2001, pp. 265-275
Authors:
Shechter, Y
Goldwaser, I
Lavon, I
Gershonov, E
Mester, B
Mironchik, M
Patt, LP
Fridkin, M
Citation: Y. Shechter et al., A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo, DRUG FUTURE, 26(7), 2001, pp. 669-676
Authors:
Ashur-Fabian, O
Giladi, E
Furman, S
Steingart, RA
Wollman, Y
Fridkin, M
Brenneman, DE
Gozes, I
Citation: O. Ashur-fabian et al., Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures, NEUROSCI L, 307(3), 2001, pp. 167-170
Authors:
Tsubery, H
Ofek, I
Cohen, S
Fridkin, M
Citation: H. Tsubery et al., N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity, PEPTIDES, 22(10), 2001, pp. 1675-1681
Authors:
Moody, TW
Leyton, J
Chan, D
Brenneman, DC
Fridkin, M
Gelber, E
Levy, A
Gozes, I
Citation: Tw. Moody et al., VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells, BREAST CANC, 68(1), 2001, pp. 55-64
Authors:
Rahimipour, S
Palivan, C
Freeman, D
Barbosa, F
Fridkin, M
Weiner, L
Mazur, Y
Gescheidt, G
Citation: S. Rahimipour et al., Hypericin derivatives: Substituent effects on radical-anion formation, PHOTOCHEM P, 74(2), 2001, pp. 149-156
Authors:
Rahimipour, S
Bilkis, I
Peron, V
Gescheidt, G
Barbosa, F
Mazur, Y
Koch, Y
Weiner, L
Fridkin, M
Citation: S. Rahimipour et al., Generation of free radicals by emodic acid and its [D-Lys(6)]GnRH-conjugate, PHOTOCHEM P, 74(2), 2001, pp. 226-236
Authors:
Shechter, Y
Preciado-Patt, L
Schreiber, G
Fridkin, M
Citation: Y. Shechter et al., Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)(7)-interferon-alpha 2, P NAS US, 98(3), 2001, pp. 1212-1217
Authors:
Scherf, T
Kasher, R
Balass, M
Fridkin, M
Fuchs, S
Katchalski-Katzir, E
Citation: T. Scherf et al., A beta-hairpin structure in a 13-mer peptide that binds alpha-bungarotoxinwith high affinity and neutralizes its toxicity, P NAS US, 98(12), 2001, pp. 6629-6634
Authors:
Rahimipour, S
Ben-Aroya, N
Fridkin, M
Koch, Y
Citation: S. Rahimipour et al., Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone, J MED CHEM, 44(22), 2001, pp. 3645-3652
Authors:
Xu, R
Abramson, J
Fridkin, M
Pecht, I
Citation: R. Xu et al., SH2 domain-containing inositol polyphosphate 5 '-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen, J IMMUNOL, 167(11), 2001, pp. 6394-6402
Authors:
Gelber, E
Granoth, R
Fridkin, M
Dreznik, Z
Brenneman, DE
Moody, TW
Gozes, I
Citation: E. Gelber et al., A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines, CANCER, 92(8), 2001, pp. 2172-2180
Authors:
Tisch-Idelson, D
Fridkin, M
Wientjes, F
Aviram, I
Citation: D. Tisch-idelson et al., Structure-function relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase, BIOCH PHARM, 61(9), 2001, pp. 1063-1071
Authors:
Tirosh, B
Fridkin, M
Tzehoval, E
Vadai, E
Lemonnier, FA
Eisenbach, L
Citation: B. Tirosh et al., Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing, J IMMUNOTH, 23(6), 2000, pp. 622-630
Authors:
Steingart, RA
Solomon, B
Brenneman, DE
Fridkin, M
Gozes, I
Citation: Ra. Steingart et al., VIP and peptides related to activity-dependent neurotropic factor protect PC12 cells against oxidative stress, J MOL NEURO, 15(3), 2000, pp. 137-145
Authors:
Sigalov, E
Fridkin, M
Brenneman, DE
Gozes, I
Citation: E. Sigalov et al., VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells, J MOL NEURO, 15(3), 2000, pp. 147-154
Authors:
Dayan, M
Segal, R
Sthoeger, Z
Waisman, A
Brosh, N
Elkayam, O
Eilat, E
Fridkin, M
Mozes, E
Citation: M. Dayan et al., Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody, J CLIN IMM, 20(3), 2000, pp. 187-194
Authors:
Sun, Q
Sekar, N
Goldwaser, I
Gershonov, E
Fridkin, M
Shechter, Y
Citation: Q. Sun et al., Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism, AM J P-ENDO, 279(2), 2000, pp. E403-E410
Authors:
Eilat, E
Fridkin, M
Mozes, E
Citation: E. Eilat et al., A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells, IMMUNOBIOL, 202(4), 2000, pp. 383-393
Authors:
Brosh, N
Dayan, M
Fridkin, M
Mozes, E
Citation: N. Brosh et al., A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice, IMMUNOL LET, 72(1), 2000, pp. 61-68
Authors:
Goldwaser, I
Gefel, D
Gershonov, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., Insulin-like effects of vanadium: basic and clinical implications, J INORG BIO, 80(1-2), 2000, pp. 21-25
Authors:
Goldwaser, I
Qian, S
Gershonov, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: Establishing criteria for optimal chelators, MOLEC PHARM, 58(4), 2000, pp. 738-746
Authors:
Yahalom, D
Koch, Y
Ben-Aroya, N
Fridkin, M
Citation: D. Yahalom et al., Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors, MOLEC PHARM, 57(4), 2000, pp. 718-724
Authors:
Zia, H
Leyton, J
Casibang, M
Hau, V
Brenneman, D
Fridkin, M
Gozes, I
Moody, TW
Citation: H. Zia et al., (N-stearyl, norleucine(17)) VIP hybrid inhibits the growth of pancreatic cancer cell lines, LIFE SCI, 66(5), 2000, pp. 379-387